D
Kura Oncology, Inc.
KURA
$7.34
$0.050.69%
D
Sell
1/23/2024Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D- from E+ on 1/23/2024 due to an increase in the total return index and volatility index.
Kura Oncology, Inc. (KURA) was upgraded to D- from E+ on 1/23/2024 due to an increase in the total return index and volatility index.
E
Sell
1/8/2024Downgrade
Kura Oncology, Inc. (KURA) was downgraded to E+ from D- on 1/8/2024 due to a decline in the valuation index and volatility index.
Kura Oncology, Inc. (KURA) was downgraded to E+ from D- on 1/8/2024 due to a decline in the valuation index and volatility index.
D
Sell
12/13/2023Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D- from E+ on 12/13/2023 due to an increase in the volatility index and total return index.
Kura Oncology, Inc. (KURA) was upgraded to D- from E+ on 12/13/2023 due to an increase in the volatility index and total return index.
E
Sell
11/6/2023Downgrade
Kura Oncology, Inc. (KURA) was downgraded to E+ from D- on 11/6/2023 due to a decline in the solvency index, volatility index and total return index. The quick ratio declined from 20.11 to 16.58.
Kura Oncology, Inc. (KURA) was downgraded to E+ from D- on 11/6/2023 due to a decline in the solvency index, volatility index and total return index. The quick ratio declined from 20.11 to 16.58.
D
Sell
10/23/2023Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D- from E+ on 10/23/2023 due to an increase in the volatility index.
Kura Oncology, Inc. (KURA) was upgraded to D- from E+ on 10/23/2023 due to an increase in the volatility index.
E
Sell
10/4/2023Downgrade
Kura Oncology, Inc. (KURA) was downgraded to E+ from D- on 10/4/2023 due to a decline in the volatility index and total return index.
Kura Oncology, Inc. (KURA) was downgraded to E+ from D- on 10/4/2023 due to a decline in the volatility index and total return index.
D
Sell
9/19/2023Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D- from E+ on 9/19/2023 due to an increase in the volatility index.
Kura Oncology, Inc. (KURA) was upgraded to D- from E+ on 9/19/2023 due to an increase in the volatility index.
E
Sell
8/29/2023Downgrade
Kura Oncology, Inc. (KURA) was downgraded to E+ from D- on 8/29/2023 due to a decline in the volatility index and total return index.
Kura Oncology, Inc. (KURA) was downgraded to E+ from D- on 8/29/2023 due to a decline in the volatility index and total return index.
D
Sell
8/14/2023Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D- from E+ on 8/14/2023 due to an increase in the solvency index, growth index and volatility index. Operating cash flow increased 28.59% from -$35.87M to -$25.62M.
Kura Oncology, Inc. (KURA) was upgraded to D- from E+ on 8/14/2023 due to an increase in the solvency index, growth index and volatility index. Operating cash flow increased 28.59% from -$35.87M to -$25.62M.
E
Sell
8/8/2023Downgrade
Kura Oncology, Inc. (KURA) was downgraded to E+ from D- on 8/8/2023 due to a decline in the volatility index and total return index.
Kura Oncology, Inc. (KURA) was downgraded to E+ from D- on 8/8/2023 due to a decline in the volatility index and total return index.
D
Sell
7/24/2023Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D- from E+ on 7/24/2023 due to an increase in the volatility index.
Kura Oncology, Inc. (KURA) was upgraded to D- from E+ on 7/24/2023 due to an increase in the volatility index.
E
Sell
7/7/2023Downgrade
Kura Oncology, Inc. (KURA) was downgraded to E+ from D- on 7/7/2023 due to a decline in the total return index and volatility index.
Kura Oncology, Inc. (KURA) was downgraded to E+ from D- on 7/7/2023 due to a decline in the total return index and volatility index.
D
Sell
6/22/2023Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D- from E+ on 6/22/2023 due to an increase in the volatility index.
Kura Oncology, Inc. (KURA) was upgraded to D- from E+ on 6/22/2023 due to an increase in the volatility index.
E
Sell
6/5/2023Downgrade
Kura Oncology, Inc. (KURA) was downgraded to E+ from D- on 6/5/2023 due to a decline in the total return index and volatility index.
Kura Oncology, Inc. (KURA) was downgraded to E+ from D- on 6/5/2023 due to a decline in the total return index and volatility index.
D
Sell
5/17/2023Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D- from E+ on 5/17/2023 due to an increase in the volatility index.
Kura Oncology, Inc. (KURA) was upgraded to D- from E+ on 5/17/2023 due to an increase in the volatility index.
E
Sell
5/5/2023Downgrade
Kura Oncology, Inc. (KURA) was downgraded to E+ from D- on 5/5/2023 due to a decline in the volatility index, total return index and growth index.
Kura Oncology, Inc. (KURA) was downgraded to E+ from D- on 5/5/2023 due to a decline in the volatility index, total return index and growth index.
D
Sell
4/18/2023Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D- from E+ on 4/18/2023 due to an increase in the volatility index and total return index.
Kura Oncology, Inc. (KURA) was upgraded to D- from E+ on 4/18/2023 due to an increase in the volatility index and total return index.
E
Sell
3/30/2023Downgrade
Kura Oncology, Inc. (KURA) was downgraded to E+ from D- on 3/30/2023 due to a decline in the volatility index and valuation index.
Kura Oncology, Inc. (KURA) was downgraded to E+ from D- on 3/30/2023 due to a decline in the volatility index and valuation index.
D
Sell
3/14/2023Downgrade
Kura Oncology, Inc. (KURA) was downgraded to D- from D on 3/14/2023 due to a decline in the volatility index.
Kura Oncology, Inc. (KURA) was downgraded to D- from D on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/23/2023Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D from D- on 02/23/2023.
Kura Oncology, Inc. (KURA) was upgraded to D from D- on 02/23/2023.
D
Sell
2/8/2023Downgrade
Kura Oncology, Inc. (KURA) was downgraded to D- from D on 2/8/2023 due to a decline in the solvency index. The quick ratio declined from 25.19 to 17.29.
Kura Oncology, Inc. (KURA) was downgraded to D- from D on 2/8/2023 due to a decline in the solvency index. The quick ratio declined from 25.19 to 17.29.
D
Sell
9/6/2022Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D from D- on 9/6/2022 due to an increase in the volatility index, growth index and valuation index. Operating cash flow increased 5.72% from -$32.18M to -$30.34M.
Kura Oncology, Inc. (KURA) was upgraded to D from D- on 9/6/2022 due to an increase in the volatility index, growth index and valuation index. Operating cash flow increased 5.72% from -$32.18M to -$30.34M.
D
Sell
7/18/2022Downgrade
Kura Oncology, Inc. (KURA) was downgraded to D- from D on 7/18/2022 due to a decline in the total return index.
Kura Oncology, Inc. (KURA) was downgraded to D- from D on 7/18/2022 due to a decline in the total return index.
D
Sell
7/1/2022Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D from D- on 7/1/2022 due to an increase in the volatility index and total return index.
Kura Oncology, Inc. (KURA) was upgraded to D from D- on 7/1/2022 due to an increase in the volatility index and total return index.
D
Sell
6/15/2022Downgrade
Kura Oncology, Inc. (KURA) was downgraded to D- from D on 6/15/2022 due to a decline in the total return index and volatility index.
Kura Oncology, Inc. (KURA) was downgraded to D- from D on 6/15/2022 due to a decline in the total return index and volatility index.
D
Sell
5/31/2022Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D from D- on 5/31/2022 due to an increase in the volatility index.
Kura Oncology, Inc. (KURA) was upgraded to D from D- on 5/31/2022 due to an increase in the volatility index.
D
Sell
5/13/2022Downgrade
Kura Oncology, Inc. (KURA) was downgraded to D- from D on 5/13/2022 due to a decline in the total return index, growth index and solvency index. Operating cash flow declined 37.73% from -$23.37M to -$32.18M.
Kura Oncology, Inc. (KURA) was downgraded to D- from D on 5/13/2022 due to a decline in the total return index, growth index and solvency index. Operating cash flow declined 37.73% from -$23.37M to -$32.18M.
D
Sell
5/4/2022Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D from E+ on 05/04/2022.
Kura Oncology, Inc. (KURA) was upgraded to D from E+ on 05/04/2022.
E
Sell
5/3/2022Downgrade
Kura Oncology, Inc. (KURA) was downgraded to E+ from D on 5/3/2022 due to a decline in the volatility index.
Kura Oncology, Inc. (KURA) was downgraded to E+ from D on 5/3/2022 due to a decline in the volatility index.
D
Sell
4/21/2022Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index and total return index.
Kura Oncology, Inc. (KURA) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index and total return index.
E
Sell
4/20/2022Downgrade
Kura Oncology, Inc. (KURA) was downgraded to E+ from D on 4/20/2022 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 24.79 to 23.07.
Kura Oncology, Inc. (KURA) was downgraded to E+ from D on 4/20/2022 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 24.79 to 23.07.
D
Sell
11/23/2021Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index and volatility index.
Kura Oncology, Inc. (KURA) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index and volatility index.
D
Sell
11/8/2021Downgrade
Kura Oncology, Inc. (KURA) was downgraded to D- from D on 11/8/2021 due to a noticeable decline in the total return index, growth index and efficiency index. Total capital declined 4.28% from $565.29M to $541.11M, and EBIT declined 0.09% from -$33.65M to -$33.68M.
Kura Oncology, Inc. (KURA) was downgraded to D- from D on 11/8/2021 due to a noticeable decline in the total return index, growth index and efficiency index. Total capital declined 4.28% from $565.29M to $541.11M, and EBIT declined 0.09% from -$33.65M to -$33.68M.
D
Sell
11/8/2017Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D from D- on 11/8/2017 due to an increase in the solvency index, total return index and efficiency index. Total capital increased 88.74% from $50.99M to $96.24M, debt to equity declined from 0.17 to 0.08, and the quick ratio increased from 10.55 to 13.36.
Kura Oncology, Inc. (KURA) was upgraded to D from D- on 11/8/2017 due to an increase in the solvency index, total return index and efficiency index. Total capital increased 88.74% from $50.99M to $96.24M, debt to equity declined from 0.17 to 0.08, and the quick ratio increased from 10.55 to 13.36.
D
Sell
9/15/2017Downgrade
Kura Oncology, Inc. (KURA) was downgraded to D- from D on 9/15/2017 due to a noticeable decline in the efficiency index, valuation index and solvency index. The quick ratio declined from 14.45 to 10.55, debt to equity increased from 0.15 to 0.17, and total capital declined 11.44% from $57.58M to $50.99M.
Kura Oncology, Inc. (KURA) was downgraded to D- from D on 9/15/2017 due to a noticeable decline in the efficiency index, valuation index and solvency index. The quick ratio declined from 14.45 to 10.55, debt to equity increased from 0.15 to 0.17, and total capital declined 11.44% from $57.58M to $50.99M.
D
Sell
10/3/2016Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D from D- on 10/3/2016 due to a noticeable increase in the total return index, volatility index and growth index. Operating cash flow increased 20.36% from -$7.31M to -$5.83M, EBIT increased 3.54% from -$7.04M to -$6.79M, and earnings per share increased from -$0.3632 to -$0.3591.
Kura Oncology, Inc. (KURA) was upgraded to D from D- on 10/3/2016 due to a noticeable increase in the total return index, volatility index and growth index. Operating cash flow increased 20.36% from -$7.31M to -$5.83M, EBIT increased 3.54% from -$7.04M to -$6.79M, and earnings per share increased from -$0.3632 to -$0.3591.
D
Sell
6/1/2016Upgraded
Kura Oncology, Inc. (KURA) was upgraded to D- from E on 6/1/2016 due to an increase in the growth index, efficiency index and solvency index. Earnings per share increased from -$0.4225 to -$0.3632, and the quick ratio increased from 17.05 to 18.3.
Kura Oncology, Inc. (KURA) was upgraded to D- from E on 6/1/2016 due to an increase in the growth index, efficiency index and solvency index. Earnings per share increased from -$0.4225 to -$0.3632, and the quick ratio increased from 17.05 to 18.3.
E
Sell
3/16/2016Downgrade
Kura Oncology, Inc. (KURA) was downgraded to E from E+ on 3/16/2016 due to a large decline in the volatility index and total return index.
Kura Oncology, Inc. (KURA) was downgraded to E from E+ on 3/16/2016 due to a large decline in the volatility index and total return index.
E
Sell
3/1/2016Upgraded
Kura Oncology, Inc. (KURA) was upgraded to E+ from E on 3/1/2016 due to an increase in the total return index and valuation index.
Kura Oncology, Inc. (KURA) was upgraded to E+ from E on 3/1/2016 due to an increase in the total return index and valuation index.
E
Sell
12/9/2015None
Kura Oncology, Inc. (KURA) was downgraded to E from U on 12/09/2015.
Kura Oncology, Inc. (KURA) was downgraded to E from U on 12/09/2015.
NASDAQ
03/18/2025 4:00PM Eastern
Quotes delayed
